Managing multiple sclerosis
Multiple sclerosis (MS) is a disease that looks different in everyone who has it—and you may know more people who have it than you think.
Mar 5, 2024
0
1
Heterocyclic Compounds: News and Research on Cladribine
MeSH tree: D03.633.100.759.590.138.300.200
Researchers identify therapeutic targets to overcome radioresistance of brain cancer cells
Post-surgical radiotherapy and temozolomide, a chemotherapeutic drug, targeting post-cell division is the current standard of care for glioblastoma (GBM)—the most prevalent and lethal primary tumor of the central nervous ...
Jan 18, 2023
0
6
Improving treatment for hairy cell leukemia
Patients with relapsed or refractory hairy cell leukemia who were treated with vemurafenib experienced excellent response and relapse-free survival, according to a recent clinical trial published in Blood.
Jan 13, 2023
0
21
Combined epigenetic and immunotherapy for blastic and classical mantle cell lymphoma
A new research paper titled "Combined epigenetic and immunotherapy for blastic and classical mantle cell lymphoma" has been published in Oncotarget.
Dec 13, 2022
0
3
Changing treatment can help MS patients, study finds
Monash University researchers have used the world's largest multiple sclerosis (MS) registry, MSBase, to provide evidence that will help those with MS take the best medicine for them.
Nov 7, 2022
0
33
